BIOS — Biosenic SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €3.83m
- €26.80m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -11.5 | -9.58 | -17.4 | -12 | -2.32 |
Depreciation | |||||
Non-Cash Items | -3.31 | -4.64 | -2.18 | -1.42 | -0.001 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.3 | 3.06 | 2.94 | 0.473 | 0.349 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -12.9 | -10.4 | -16.1 | -12.8 | -1.91 |
Capital Expenditures | -0.296 | -0.31 | -0.093 | -0.207 | -0.005 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.001 | 0.008 | 12 | 0.003 | 1.96 |
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.295 | -0.302 | 11.9 | -0.204 | 1.95 |
Financing Cash Flow Items | -0.805 | -0.86 | -3.83 | -1 | -0.203 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 13 | 11.2 | 10.2 | 7.85 | 1.04 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.237 | 0.459 | 6.01 | -5.14 | 1.09 |